<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM">
      <PMID Version="1">35172689</PMID>
      <DateCompleted>
        <Year>2022</Year>
        <Month>03</Month>
        <Day>07</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2022</Year>
        <Month>03</Month>
        <Day>07</Day>
      </DateRevised>
      <Article PubModel="Print">
        <Journal>
          <ISSN IssnType="Electronic">1525-6049</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>44</Volume>
            <Issue>1</Issue>
            <PubDate>
              <Year>2022</Year>
              <Month>Dec</Month>
            </PubDate>
          </JournalIssue>
          <Title>Renal failure</Title>
          <ISOAbbreviation>Ren Fail</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Endoplasmic reticulum stress mediates parathyroid hormone-induced apoptosis in vascular smooth muscle cells.</ArticleTitle>
        <Pagination>
          <StartPage>126</StartPage>
          <EndPage>136</EndPage>
          <MedlinePgn>126-136</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1080/0886022X.2022.2027248</ELocationID>
        <Abstract>
          <AbstractText>Vascular calcification is one of the most common complications of chronic kidney disease (CKD), which is closely associated with increased mortality and morbidity rates of CKD patients. It has been reported that increased parathyroid hormone (PTH) aggravates vascular calcification in CKD patients. However, the direct role of PTH in vascular smooth muscle cells (VSMCs) is less elucidated. Here, we present evidence that PTH promotes apoptosis of VSMCs and endoplasmic reticulum (ER) stress participates in this process. Human aorta vascular smooth muscle cells (HASMCs) were treated with different concentrations of PTH for various time. HASMC apoptosis was detected by flow cytometry. Expression of phosphorylated (p)-PERK, CHOP, IRE1, p-JNK, and cleaved caspase 3 was determined by Western blotting. We found that PTH induced HASMC apoptosis and increased the expression of cleaved caspase 3. Furthermore, PTH activated PERK-CHOP and IRE1-JNK ER stress pathways. Either inhibition of JNK by SP600125 or CHOP by siRNA ameliorated PTH-induced apoptosis in HASMCs. We therefore suggest that ER stress participates in PTH-induced apoptosis of VSMCs, which may be a possible mechanism of PTH-promoted vascular calcification in CKD patients.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Duan</LastName>
            <ForeName>Shuzhong</ForeName>
            <Initials>S</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Nephrology, Beijing Friendship Hospital, Faculty of Kidney Diseases, Capital Medical University, Beijing, China.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Department of Nephrology, Chengde Medical University Affiliated Hospital, Chengde, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Chen</LastName>
            <ForeName>Xinpan</ForeName>
            <Initials>X</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Nephrology, Beijing Friendship Hospital, Faculty of Kidney Diseases, Capital Medical University, Beijing, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Liu</LastName>
            <ForeName>Yingjie</ForeName>
            <Initials>Y</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Nephrology, Beijing Friendship Hospital, Faculty of Kidney Diseases, Capital Medical University, Beijing, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Guo</LastName>
            <ForeName>Weikang</ForeName>
            <Initials>W</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Nephrology, Beijing Friendship Hospital, Faculty of Kidney Diseases, Capital Medical University, Beijing, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Liu</LastName>
            <ForeName>Wenhu</ForeName>
            <Initials>W</Initials>
            <Identifier Source="ORCID">0000-0002-6532-4394</Identifier>
            <AffiliationInfo>
              <Affiliation>Department of Nephrology, Beijing Friendship Hospital, Faculty of Kidney Diseases, Capital Medical University, Beijing, China.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
      </Article>
      <MedlineJournalInfo>
        <MedlineTA>Ren Fail</MedlineTA>
        <NlmUniqueID>8701128</NlmUniqueID>
        <ISSNLinking>0886-022X</ISSNLinking>
      </MedlineJournalInfo>
      <ChemicalList>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D000873">Anthracenes</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D010281">Parathyroid Hormone</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D034741">RNA, Small Interfering</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>145891-90-3</RegistryNumber>
          <NameOfSubstance UI="D051701">Activating Transcription Factor 4</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>1TW30Y2766</RegistryNumber>
          <NameOfSubstance UI="C432165">pyrazolanthrone</NameOfSubstance>
        </Chemical>
      </ChemicalList>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D051701" MajorTopicYN="N">Activating Transcription Factor 4</DescriptorName>
          <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000873" MajorTopicYN="N">Anthracenes</DescriptorName>
          <QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D001011" MajorTopicYN="N">Aorta</DescriptorName>
          <QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName>
          <QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D017209" MajorTopicYN="Y">Apoptosis</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D002478" MajorTopicYN="N">Cells, Cultured</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D059865" MajorTopicYN="Y">Endoplasmic Reticulum Stress</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D020935" MajorTopicYN="N">MAP Kinase Signaling System</DescriptorName>
          <QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D032389" MajorTopicYN="N">Myocytes, Smooth Muscle</DescriptorName>
          <QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D010281" MajorTopicYN="N">Parathyroid Hormone</DescriptorName>
          <QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D010766" MajorTopicYN="N">Phosphorylation</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D034741" MajorTopicYN="N">RNA, Small Interfering</DescriptorName>
          <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D051436" MajorTopicYN="N">Renal Insufficiency, Chronic</DescriptorName>
          <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
          <QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D061205" MajorTopicYN="N">Vascular Calcification</DescriptorName>
          <QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName>
          <QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">CKD</Keyword>
        <Keyword MajorTopicYN="N">ER stress</Keyword>
        <Keyword MajorTopicYN="N">PTH</Keyword>
        <Keyword MajorTopicYN="N">apoptosis</Keyword>
        <Keyword MajorTopicYN="N">vascular calcification</Keyword>
      </KeywordList>
      <CoiStatement>No potential conflict of interest was reported by the author(s).</CoiStatement>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="entrez">
          <Year>2022</Year>
          <Month>2</Month>
          <Day>17</Day>
          <Hour>5</Hour>
          <Minute>28</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2022</Year>
          <Month>2</Month>
          <Day>18</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2022</Year>
          <Month>3</Month>
          <Day>8</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">35172689</ArticleId>
        <ArticleId IdType="pmc">PMC8856047</ArticleId>
        <ArticleId IdType="doi">10.1080/0886022X.2022.2027248</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>Nakanishi T, Nanami M, Kuragano T.. 
The pathogenesis of CKD complications; attack of dysregulated iron and phosphate metabolism. Free Radic Biol Med. 2020;157:55–62.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">31978539</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Shroff R, Long DA, Shanahan C.. 
Mechanistic insights into vascular calcification in CKD. J Am Soc Nephrol. 2013;24(2):179–189.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">23138485</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lee SH, Ok S-H, Subbarao RB, et al. . 
Vascular calcification – new insights into its mechanism. Int J Med Sci. 2020;17(1):21–32.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC6945562</ArticleId>
            <ArticleId IdType="pubmed">31929735</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Chang JR, Sun N, Liu Y, et al. . 
Erythropoietin attenuates vascular calcification by inhibiting endoplasmic reticulum stress in rats with chronic kidney disease. Peptides. 2020; 123:170181.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">31689455</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Shi Y, Wang S, Peng H, et al. . 
Fibroblast growth factor 21 attenuates vascular calcification by alleviating endoplasmic reticulum stress mediated apoptosis in rats. Int J Biol Sci. 2019;15(1):138–147.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC6329919</ArticleId>
            <ArticleId IdType="pubmed">30662354</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Shanahan CM, Furmanik M.. 
Endoplasmic reticulum stress in arterial smooth muscle cells: a novel regulator of vascular disease. Curr Cardiol Rev. 2017;13(2):94–105.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5440785</ArticleId>
            <ArticleId IdType="pubmed">27758694</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Guzel E, Arlier S, Guzeloglu-Kayisli O, et al. . 
Endoplasmic reticulum stress and homeostasis in reproductive physiology and pathology. Int J Mol Sci. 2017;18:792.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5412376</ArticleId>
            <ArticleId IdType="pubmed">28397763</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Iurlaro R, Muñoz-Pinedo C.. 
Cell death induced by endoplasmic reticulum stress. Febs J. 2016;283(14):2640–2652.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">26587781</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ryoo HD.
Long and short (timeframe) of endoplasmic reticulum stress-induced cell death. Febs J. 2016;283(20):3718–3722.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5656986</ArticleId>
            <ArticleId IdType="pubmed">27191701</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Nakagawa T, Zhu H, Morishima N, et al. . 
Caspase-12 mediates endoplasmic-reticulum-specific apoptosis and cytotoxicity by amyloid-beta. Nature. 2000;403(6765):98–103.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">10638761</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zuo S, Kong D, Wang C, et al. . 
CRTH2 promotes endoplasmic reticulum stress-induced cardiomyocyte apoptosis through M-calpain. EMBO Mol Med. 2018;10(3):e8237.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5840549</ArticleId>
            <ArticleId IdType="pubmed">29335338</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Coen G.
Calcimimetics, parathyroid hormone, and vascular calcification in chronic kidney disease. Kidney Int. 2008;74(10):1229–1231.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">18974757</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Carrillo-López N, Panizo S, Alonso-Montes C, et al. . 
High-serum phosphate and parathyroid hormone distinctly regulate bone loss and vascular calcification in experimental chronic kidney disease. Nephrol Dial Transplant. 2019;34(6):934–941.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">30189026</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Malluche HH, Blomquist G, Monier-Faugere MC, et al. . 
High parathyroid hormone level and osteoporosis predict progression of coronary artery calcification in patients on dialysis. J Am Soc Nephrol. 2015;26(10):2534–2544.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4587691</ArticleId>
            <ArticleId IdType="pubmed">25838468</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Liu Y, Wu Y, Diao Z, et al. . 
Resveratrol inhibits parathyroid hormone-induced apoptosis in human aortic smooth muscle cells by upregulating sirtuin 1. Ren Fail. 2019;41(1):401–407.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC6534218</ArticleId>
            <ArticleId IdType="pubmed">31106631</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Guo Y, Bao S, Guo W, et al. . 
Bone marrow mesenchymal stem cell-derived exosomes alleviate high phosphorus-induced vascular smooth muscle cells calcification by modifying microRNA profiles. Funct Integr Genomics. 2019;19(4):633–643.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">30850904</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Guo W, Ding J, Zhang A, et al. . 
The inhibitory effect of quercetin on asymmetric dimethylarginine-induced apoptosis is mediated by the endoplasmic reticulum stress pathway in glomerular endothelial cells. Int J Mol Sci. 2014;15(1):484–503.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3907821</ArticleId>
            <ArticleId IdType="pubmed">24451129</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mohlin C, Taylor L, Ghosh F, et al. . 
Autophagy and ER-stress contribute to photoreceptor degeneration in cultured adult porcine retina. Brain Res. 2014; 1585:167–183.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">25173074</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>García de la Cadena S, Massieu L.. 
Caspases and their role in inflammation and ischemic neuronal death. Focus on caspase-12. Apoptosis. 2016;21(7):763–777.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">27142195</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Cozzolino M, Ciceri P, Galassi A, et al. . 
The key role of phosphate on vascular calcification. Toxins(Basel). 2019; 11:213.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC6521180</ArticleId>
            <ArticleId IdType="pubmed">30970562</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Chen J, Budoff MJ, Reilly MP, CRIC Investigators, et al.. 
Coronary artery calcification and risk of cardiovascular disease and death among patients with chronic kidney disease. JAMA Cardiol. 2017;2(6):635–643.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5798875</ArticleId>
            <ArticleId IdType="pubmed">28329057</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Nelson AJ, Raggi P, Wolf M, et al. . 
Targeting vascular calcification in chronic kidney disease. JACC Basic Transl Sci. 2020;5(4):398–412.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC7188874</ArticleId>
            <ArticleId IdType="pubmed">32368697</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Rogers MA, Aikawa E.. 
Cardiovascular calcification: artificial intelligence and big data accelerate mechanistic discovery. Nat Rev Cardiol. 2019;16(5):261–274.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">30531869</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lossi L, Castagna C, Merighi A.. 
Caspase-3 mediated cell death in the normal development of the mammalian cerebellum. Int J Mol Sci. 2018; 19: 3999.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC6321612</ArticleId>
            <ArticleId IdType="pubmed">30545052</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Masuda M, Miyazaki-Anzai S, Keenan AL, et al. . 
Activating transcription factor-4 promotes mineralization in vascular smooth muscle cells. JCI Insight. 2016;1(18):e88646.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5085604</ArticleId>
            <ArticleId IdType="pubmed">27812542</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ochoa CD, Wu RF, Terada LS.. 
ROS signaling and ER stress in cardiovascular disease. Mol Aspects Med. 2018; 63:18–29.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC6139279</ArticleId>
            <ArticleId IdType="pubmed">29559224</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Panda DK, Bai X, Sabbagh Y, et al. . 
Defective interplay between mTORC1 activity and endoplasmic reticulum stress-unfolded protein response in uremic vascular calcification. Am J Physiol Renal Physiol. 2018;314(6):F1046–1046F1061.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">29357413</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Duan XH, Chang JR, Zhang J, et al. . 
Activating transcription factor 4 is involved in endoplasmic reticulum stress-mediated apoptosis contributing to vascular calcification. Apoptosis. 2013;18(9):1132–1144.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">23686245</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zhu Q, Guo R, Liu C, et al. . 
Endoplasmic reticulum stress-mediated apoptosis contributing to high glucose-induced vascular smooth muscle cell calcification. J Vasc Res. 2015;52(5):291–298.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">26890314</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Furmanik M, van Gorp R, Whitehead M, et al. . 
Endoplasmic reticulum stress mediates vascular smooth muscle cell calcification via increased release of Grp78-Loaded extracellular vesicles. ATVB. 2021;41(2):898–914. ATVBAHA120315506.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC7837691</ArticleId>
            <ArticleId IdType="pubmed">33297752</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Maltais JS, Simard E, Froehlich U, et al. . 
iRAGE as a novel carboxymethylated peptide that prevents advanced glycation end product-induced apoptosis and endoplasmic reticulum stress in vascular smooth muscle cells. Pharmacol Res. 2016; 104:176–185.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">26707030</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Shiozaki Y, Okamura K, Kohno S, et al. . 
The CDK9-cyclin T1 complex mediates saturated fatty acid-induced vascular calcification by inducing expression of the transcription factor CHOP. J Biol Chem. 2018;293(44):17008–17020.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC6222109</ArticleId>
            <ArticleId IdType="pubmed">30209133</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zou Z, Wang L, Zhou Z, et al. . 
Simultaneous incorporation of PTH(1-34) and nano-hydroxyapatite into chitosan/alginate hydrogels for efficient bone regeneration. Bioact Mater. 2021;6(6):1839–1851.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC7723774</ArticleId>
            <ArticleId IdType="pubmed">33336115</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ishikawa M, Akishita M, Kozaki K, et al. . 
Amino-terminal fragment (1-34) of parathyroid hormone-related protein inhibits migration and proliferation of cultured vascular smooth muscle cells. Atherosclerosis. 1998;136(1):59–66.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">9544732</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Rashid G, Plotkin E, Klein O, et al. . 
Parathyroid hormone decreases endothelial osteoprotegerin secretion: role of protein kinase a and C. Am J Physiol Renal Physiol. 2009;296(1):F60–66.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">18945829</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Benson T, Menezes T, Campbell J, et al. . 
Mechanisms of vasodilation to PTH 1-84, PTH 1-34, and PTHrP 1-34 in rat bone resistance arteries. Osteoporos Int. 2016;27(5):1817–1826.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">26733378</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ito N, Prideaux M, Wijenayaka AR, et al. . 
Sclerostin directly stimulates osteocyte synthesis of fibroblast growth factor-23. Calcif Tissue Int. 2021;109(1):66–76.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">33616712</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Guo F, Han X, Wu Z, et al. . 
ATF6a, a Runx2-activable transcription factor, is a new regulator of chondrocyte hypertrophy. J Cell Sci. 2016;129(4):717–728.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">26527399</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
